Search clinical trials for: Caplacizumab Dose 2 sc (multiple-dose)
Total 1174 results
-
The Cleveland ClinicCompletedOveractive Bladder | Urge Incontinence | Urinary Incontinence, Urge | Overactive Bladder SyndromeUnited States
-
AstraZenecaCompletedHypertriglyceridemiaUnited States
-
Altheos, Inc.UnknownPrimary Open Angle Glaucoma | Ocular HypertensionUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Estonia, France, Georgia, Germany, Guatemala, Italy, Latvia, Lithuania, Mexico, New Zealand, Poland, Russian Federation, South Africa, Spain, Ukraine
-
Boehringer IngelheimCompleted
-
AblynxWithdrawnRespiratory Syncytial Virus Lower Respiratory Tract InfectionBelgium, Spain, Australia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveNetherlands
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Teva Branded Pharmaceutical Products R&D, Inc.Active, not recruitingSchizophreniaUnited States, Bulgaria, China, Romania, Turkey
-
Wang MinLanyue Biotech (Hangzhou) Co., Ltd.Recruiting
-
COVID-19 Prevention NetworkNational Institute of Allergy and Infectious Diseases (NIAID); Medical Research...CompletedHIV Infections | COVID-19 | SARS-CoV-2 InfectionUganda, Malawi, South Africa, Botswana, Zambia, Kenya, Swaziland
-
Jiangsu Province Centers for Disease Control and...Active, not recruiting
-
CelltrionCompletedHealth, SubjectiveUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, France, Israel, Mexico, South Africa
-
Mansoura UniversityCompletedProstaglandin E2 "Misoprostol" Prior Abdominal Myomectomy
-
Otsuka Pharmaceutical Co., Ltd.Withdrawn
-
Boehringer IngelheimEli Lilly and CompanyCompletedHyperglycemia | Diabetes Mellitus, Type 2United States, Brazil, Canada, Czech Republic, Egypt, France, Germany, Guatemala, Korea, Republic of, Lebanon, Malaysia, Mexico, Peru, Philippines, Russian Federation, Serbia, Spain, Taiwan, Thailand, Turkey, United Kingdom
-
Emory UniversityGeorgia Center for Oncology Research & EducationNot yet recruitingHuman Immunodeficiency Virus | Human Papilloma Virus | Anal Intraepithelial Neoplasia | High-Grade Squamous Intraepithelial LesionsUnited States
-
Hookipa Biotech GmbHNot yet recruitingHuman Immunodeficiency Virus (HIV) InfectionUnited States
-
Cinclus Pharma AGCompleted
-
AIM Vaccine Co., Ltd.Ningbo Rongan Biological Pharmaceutical Co. Ltd.; LiveRNA Therapeutics Inc.Not yet recruiting
-
AstraZenecaCompletedAsthma (Part 1) | COPD (Part 2)United Kingdom
-
Mannkind CorporationCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1United States
-
Boston Medical CenterMerck Sharp & Dohme LLCRecruiting
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Croatia, Czech Republic, Denmark, Estonia, France, Georgia, Greece, Hong Kong, Hungary, India, Indonesia, Israel, Italy, Japan, Korea, Republic of, Malaysia and more
-
Abu Dhabi Stem Cells CenterRecruitingType 1 DiabetesUnited Arab Emirates
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Denmark, Estonia, Hungary, Italy, Lebanon, Malaysia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Spain, Sweden, Taiwan
-
CyanVac LLCCompleted
-
University Hospitals Cleveland Medical CenterWithdrawn
-
University of North Carolina, Chapel HillOrganic TechnologiesCompleted
-
Instituto Nacional de Salud Publica, MexicoNational Council of Science and Technology, Mexico; Universidad Nacional Autonoma...Completed
-
Rovi Pharmaceuticals LaboratoriesRecruiting
-
AstraZenecaRecruitingHyperkalaemiaChina, Germany, United States, Ukraine, Spain, Japan, United Kingdom, Canada, Poland, Romania, Russian Federation, Brazil
-
University of Texas Southwestern Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertensionUnited States
-
Boehringer IngelheimCompleted
-
Enimmune CorporationCompleted
-
AgonOx, Inc.Providence St Joseph Health; Phio Pharmaceuticals Corp.RecruitingMelanoma | Gynecologic Cancer | Colorectal Cancer | Lung Cancer | HNSCC | Urogenital CancerUnited States
-
University Hospital, LimogesWithdrawnNephrotic Syndrome Steroid-Dependent | Interleukin 2
-
Consorzio per Valutazioni Biologiche e FarmacologicheEuropean CommissionCompletedChronic Iron OverloadItaly, Cyprus, Egypt
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
University of ZurichCompleted
-
MicuRxWorldwide Clinical TrialsCompleted
-
Bristol-Myers SquibbCardioxyl Pharmaceuticals, IncCompletedHeart FailureUnited States
-
Ain Shams UniversityCompletedLong Acting Insulin in Control of Gestational Diabetes MellitusEgypt
-
Schering-PloughCompleted
-
Ciusss de L'Est de l'Île de MontréalCompletedIntubation; Difficult or FailedCanada
-
Makerere UniversityCompletedPost Operative InfectionsUganda
-
BiogenCompleted